探索菌体及其应用的潜力
Khushal Khambhati1, Gargi Bhattacharjee1, Nisarg Gohil1
1Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.
Progress in molecular biology and translational science
|September 22, 2023
概括
菌体 (菌体) 正在成为抗生素的有希望的替代品,用于治疗多抗药性细菌感染. 这些病毒可以自我复制,并提供了一种未来的方法来打击抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 抗生素耐药性增加构成了全球卫生危机,多药耐药 (MDR) 病原体越来越难以治疗.
- 过度使用和滥用抗生素加速了耐药微生物的发展,通过诸如水平基因转移和突变等机制.
- 传统的抗生素正在失去有效性,需要探索替代治疗策略.
研究的目的:
- 探索菌体 (菌体) 作为传统抗生素的可行替代品,用于对抗MDR细菌病原体.
- 突出菌体在应对抗生素耐药性日益增长的挑战方面的潜力.
- 审查菌体治疗的历史背景和最近的复兴.
主要方法:
- 对细菌治疗的历史和当前科学文献的审查.
- 对菌体特征的分析,包括化和 lysogenic 生命周期和自我复制能力.
- 探索菌体在医学及其他领域的多样化应用.
主要成果:
- 细菌菌体历史上在20世纪初被用作抗生素的替代品,但随着抗生素的发现而下降.
- 菌体显示出作为未来的抗菌武器库的潜力,因为它们能够使用细菌宿主机器进行自我复制.
- 菌体为治疗抗生素耐药细菌引起的感染提供了一个有希望的替代方案.
结论:
- 菌体疗法是抗生素的可行和新兴替代品,用于治疗多药耐药细菌感染.
- 菌体的独特生物特性,如自我复制和有针对性的细菌消除,使它们成为未来抗菌策略的关键工具.
- 对菌体的进一步研究和应用对于开发针对耐药病原体的新型治疗方法至关重要.
相关概念视频
01:30Lytic Cycle of Bacteriophages
70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
01:26DNA Bacteriophages
39
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
39
01:29Microorganisms in Medicine and Therapeutics
49
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
49
00:43Lysogenic Cycle of Bacteriophages
62.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.3K
01:16Viral Replication: Lysogenic Cycle
43
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
43
02:53CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K